Search hospitals > Kansas > Topeka

Cotton-O'Neil Clinical Research Center, Digestive Health

Claim this profile
Topeka, Kansas 66606
Global Leader in Inflammatory Bowel Disease
Global Leader in Ulcerative Colitis
Conducts research for Ulcer
Conducts research for Crohn's Disease
Conducts research for Gastroparesis
45 reported clinical trials
1 medical researcher
Photo of Cotton-O'Neil Clinical Research Center, Digestive Health in TopekaPhoto of Cotton-O'Neil Clinical Research Center, Digestive Health in TopekaPhoto of Cotton-O'Neil Clinical Research Center, Digestive Health in Topeka

Summary

Cotton-O'Neil Clinical Research Center, Digestive Health is a medical facility located in Topeka, Kansas. This center is recognized for care of Inflammatory Bowel Disease, Ulcerative Colitis, Ulcer, Crohn's Disease, Gastroparesis and other specialties. Cotton-O'Neil Clinical Research Center, Digestive Health is involved with conducting 45 clinical trials across 21 conditions. There are 1 research doctors associated with this hospital, such as Curtis Baum, MD.

Top PIs

Clinical Trials running at Cotton-O'Neil Clinical Research Center, Digestive Health

Crohn's Disease
Ulcerative Colitis
Ulcer
Inflammatory Bowel Disease
Thyroid Disease
Hypothyroidism
Image of trial facility.

Tulisokibart

for Crohn's Disease

The purpose of this protocol is to evaluate the efficacy and safety of tulisokibart in participants with moderately to severely active Crohn's disease. Study 1's primary hypotheses are that at least 1 tulisokibart dose level is superior to Placebo in the proportion of participants achieving clinical remission per Crohn's Disease Activity Index score (\<150, US/FDA) or per stool frequency and abdominal pain score (EU/EMA) and in the proportion of participants achieving endoscopic response at Week 52 (US/FDA and EU/EMA), and that at least 1 tulisokibart dose level is superior to Placebo in the proportion of participants achieving clinical remission per Crohn's Disease Activity Index score (\<150, US/FDA) or per stool frequency and abdominal pain score (EU/EMA) and in the proportion of participants achieving endoscopic response at Week 12 (US/FDA and EU/EMA). Study 2's primary hypothesis is that at least 1 tulisokibart dose level is superior to Placebo in the proportion of participants achieving clinical remission per Crohn's Disease Activity Index score (\<150, US/FDA) or stool frequency and abdominal pain score (EU/EMA) and in the proportion of participants achieving endoscopic response at Week 12 (US/FDA and EU/EMA).
Recruiting1 award Phase 31 criteria
Image of trial facility.

Oral Ozanimod

for Crohn's Disease

This is a study to explore the effect of oral ozanimod as an induction treatment for participants with moderately to severely active Crohn's Disease.
Recruiting1 award Phase 34 criteria
Image of trial facility.

Ozanimod

for Crohn's Disease

This is a study to demonstrate the effect of oral ozanimod as maintenance therapy in participants with moderately to severely active Crohn's Disease.
Recruiting1 award Phase 33 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Cotton-O'Neil Clinical Research Center, Digestive Health?
Cotton-O'Neil Clinical Research Center, Digestive Health is a medical facility located in Topeka, Kansas. This center is recognized for care of Inflammatory Bowel Disease, Ulcerative Colitis, Ulcer, Crohn's Disease, Gastroparesis and other specialties. Cotton-O'Neil Clinical Research Center, Digestive Health is involved with conducting 45 clinical trials across 21 conditions. There are 1 research doctors associated with this hospital, such as Curtis Baum, MD.